Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy.

Authors:
Liu X; Zhang Q; Liang Y; Xiong S; Cai Y and 7 more

Journal:
Acta Pharm Sin B

Publication Year: 2023

DOI:
10.1016/j.apsb.2023.07.012

PMCID:
PMC10692376

PMID:
38045048

Journal Information

Full Title: Acta Pharm Sin B

Abbreviation: Acta Pharm Sin B

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"single-cell rna-seq data are available from the liver cancer single-cell data under accession number gse125449 ."

Code Sharing
Evidence found in paper:

"Conflicts of interest The authors declare no conflicts of interest."

Evidence found in paper:

"This work was supported by the 10.13039/501100001809National Natural Science Foundation of China (82171944, 81873899, China), the 10.13039/501100003453Natural Science Foundation of Guangdong Province (2021A1515012611, China), the 10.13039/501100001809National Natural Science Foundation of China (82171952, 81801719, China), Postdoctoral 10.13039/100006190Research and Development Fund Project of 10.13039/501100013365West China Hospital (2023HXBH063, China). The authors acknowledged the Sun Yat-sen Memorial Hospital of Sun Yat-sen University and West China Hospital of Sichuan University for technical assistance."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025